img

Global Pediatric Gastrointestinal Drugs Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pediatric Gastrointestinal Drugs Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Pediatric Gastrointestinal Drugs Market
The global Pediatric Gastrointestinal Drugs market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pediatric Gastrointestinal Drugs is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Pediatric Gastrointestinal Drugs is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Pediatric Gastrointestinal Drugs is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key companies of Pediatric Gastrointestinal Drugs include AstraZeneca, Sanofi, Aptalis, Eisai, Pfizer, Zeria (Tillotts), GlaxoSmithKline, Salix Pharmaceuticals and Perrigo, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Pediatric Gastrointestinal Drugs market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Pediatric Gastrointestinal Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pediatric Gastrointestinal Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pediatric Gastrointestinal Drugs revenue, market share and industry ranking of main companies, data from 2018 to 2024. Identification of the major stakeholders in the global Pediatric Gastrointestinal Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2034. Evaluation and forecast the market size for Pediatric Gastrointestinal Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including AstraZeneca, Sanofi, Aptalis, Eisai, Pfizer, Zeria (Tillotts), GlaxoSmithKline, Salix Pharmaceuticals and Perrigo, etc.



By Company


AstraZeneca
Sanofi
Aptalis
Eisai
Pfizer
Zeria (Tillotts)
GlaxoSmithKline
Salix Pharmaceuticals
Perrigo
Abbott
Honz Pharmaceutical
Shandong DYNE Marine Biopharmaceutical
Sunflower Pharmaceutical
Jiangzhong Pharmaceutical
Yabao Pharmaceutical
Jumpcan Pharmaceutical
Hansen Pharmaceutical
Segment by Type
Tablets
Pills
Oral Liquid

Segment by Application


Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Pediatric Gastrointestinal Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Pediatric Gastrointestinal Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pediatric Gastrointestinal Drugs revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Gastrointestinal Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Tablets
1.2.3 Pills
1.2.4 Oral Liquid
1.3 Market by Application
1.3.1 Global Pediatric Gastrointestinal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Gastrointestinal Drugs Market Perspective (2018-2034)
2.2 Global Pediatric Gastrointestinal Drugs Growth Trends by Region
2.2.1 Pediatric Gastrointestinal Drugs Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Pediatric Gastrointestinal Drugs Historic Market Size by Region (2018-2024)
2.2.3 Pediatric Gastrointestinal Drugs Forecasted Market Size by Region (2024-2034)
2.3 Pediatric Gastrointestinal Drugs Market Dynamics
2.3.1 Pediatric Gastrointestinal Drugs Industry Trends
2.3.2 Pediatric Gastrointestinal Drugs Market Drivers
2.3.3 Pediatric Gastrointestinal Drugs Market Challenges
2.3.4 Pediatric Gastrointestinal Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Pediatric Gastrointestinal Drugs by Players
3.1.1 Global Pediatric Gastrointestinal Drugs Revenue by Players (2018-2024)
3.1.2 Global Pediatric Gastrointestinal Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Pediatric Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Pediatric Gastrointestinal Drugs, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Pediatric Gastrointestinal Drugs Market Concentration Ratio
3.4.1 Global Pediatric Gastrointestinal Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Gastrointestinal Drugs Revenue in 2022
3.5 Global Key Players of Pediatric Gastrointestinal Drugs Head office and Area Served
3.6 Global Key Players of Pediatric Gastrointestinal Drugs, Product and Application
3.7 Global Key Players of Pediatric Gastrointestinal Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Gastrointestinal Drugs Breakdown Data by Type
4.1 Global Pediatric Gastrointestinal Drugs Historic Market Size by Type (2018-2024)
4.2 Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Type (2024-2034)
5 Pediatric Gastrointestinal Drugs Breakdown Data by Application
5.1 Global Pediatric Gastrointestinal Drugs Historic Market Size by Application (2018-2024)
5.2 Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Pediatric Gastrointestinal Drugs Market Size (2018-2034)
6.2 North America Pediatric Gastrointestinal Drugs Market Size by Type
6.2.1 North America Pediatric Gastrointestinal Drugs Market Size by Type (2018-2024)
6.2.2 North America Pediatric Gastrointestinal Drugs Market Size by Type (2024-2034)
6.2.3 North America Pediatric Gastrointestinal Drugs Market Share by Type (2018-2034)
6.3 North America Pediatric Gastrointestinal Drugs Market Size by Application
6.3.1 North America Pediatric Gastrointestinal Drugs Market Size by Application (2018-2024)
6.3.2 North America Pediatric Gastrointestinal Drugs Market Size by Application (2024-2034)
6.3.3 North America Pediatric Gastrointestinal Drugs Market Share by Application (2018-2034)
6.4 North America Pediatric Gastrointestinal Drugs Market Size by Country
6.4.1 North America Pediatric Gastrointestinal Drugs Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America Pediatric Gastrointestinal Drugs Market Size by Country (2018-2024)
6.4.3 North America Pediatric Gastrointestinal Drugs Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Pediatric Gastrointestinal Drugs Market Size (2018-2034)
7.2 Europe Pediatric Gastrointestinal Drugs Market Size by Type
7.2.1 Europe Pediatric Gastrointestinal Drugs Market Size by Type (2018-2024)
7.2.2 Europe Pediatric Gastrointestinal Drugs Market Size by Type (2024-2034)
7.2.3 Europe Pediatric Gastrointestinal Drugs Market Share by Type (2018-2034)
7.3 Europe Pediatric Gastrointestinal Drugs Market Size by Application
7.3.1 Europe Pediatric Gastrointestinal Drugs Market Size by Application (2018-2024)
7.3.2 Europe Pediatric Gastrointestinal Drugs Market Size by Application (2024-2034)
7.3.3 Europe Pediatric Gastrointestinal Drugs Market Share by Application (2018-2034)
7.4 Europe Pediatric Gastrointestinal Drugs Market Size by Country
7.4.1 Europe Pediatric Gastrointestinal Drugs Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Pediatric Gastrointestinal Drugs Market Size by Country (2018-2024)
7.4.3 Europe Pediatric Gastrointestinal Drugs Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Pediatric Gastrointestinal Drugs Market Size (2018-2034)
8.2 China Pediatric Gastrointestinal Drugs Market Size by Type
8.2.1 China Pediatric Gastrointestinal Drugs Market Size by Type (2018-2024)
8.2.2 China Pediatric Gastrointestinal Drugs Market Size by Type (2024-2034)
8.2.3 China Pediatric Gastrointestinal Drugs Market Share by Type (2018-2034)
8.3 China Pediatric Gastrointestinal Drugs Market Size by Application
8.3.1 China Pediatric Gastrointestinal Drugs Market Size by Application (2018-2024)
8.3.2 China Pediatric Gastrointestinal Drugs Market Size by Application (2024-2034)
8.3.3 China Pediatric Gastrointestinal Drugs Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Pediatric Gastrointestinal Drugs Market Size (2018-2034)
9.2 Asia Pediatric Gastrointestinal Drugs Market Size by Type
9.2.1 Asia Pediatric Gastrointestinal Drugs Market Size by Type (2018-2024)
9.2.2 Asia Pediatric Gastrointestinal Drugs Market Size by Type (2024-2034)
9.2.3 Asia Pediatric Gastrointestinal Drugs Market Share by Type (2018-2034)
9.3 Asia Pediatric Gastrointestinal Drugs Market Size by Application
9.3.1 Asia Pediatric Gastrointestinal Drugs Market Size by Application (2018-2024)
9.3.2 Asia Pediatric Gastrointestinal Drugs Market Size by Application (2024-2034)
9.3.3 Asia Pediatric Gastrointestinal Drugs Market Share by Application (2018-2034)
9.4 Asia Pediatric Gastrointestinal Drugs Market Size by Region
9.4.1 Asia Pediatric Gastrointestinal Drugs Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia Pediatric Gastrointestinal Drugs Market Size by Region (2018-2024)
9.4.3 Asia Pediatric Gastrointestinal Drugs Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Pediatric Gastrointestinal Drugs Introduction
11.1.4 AstraZeneca Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024)
11.1.5 AstraZeneca Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Pediatric Gastrointestinal Drugs Introduction
11.2.4 Sanofi Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024)
11.2.5 Sanofi Recent Developments
11.3 Aptalis
11.3.1 Aptalis Company Details
11.3.2 Aptalis Business Overview
11.3.3 Aptalis Pediatric Gastrointestinal Drugs Introduction
11.3.4 Aptalis Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024)
11.3.5 Aptalis Recent Developments
11.4 Eisai
11.4.1 Eisai Company Details
11.4.2 Eisai Business Overview
11.4.3 Eisai Pediatric Gastrointestinal Drugs Introduction
11.4.4 Eisai Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024)
11.4.5 Eisai Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Pediatric Gastrointestinal Drugs Introduction
11.5.4 Pfizer Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024)
11.5.5 Pfizer Recent Developments
11.6 Zeria (Tillotts)
11.6.1 Zeria (Tillotts) Company Details
11.6.2 Zeria (Tillotts) Business Overview
11.6.3 Zeria (Tillotts) Pediatric Gastrointestinal Drugs Introduction
11.6.4 Zeria (Tillotts) Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024)
11.6.5 Zeria (Tillotts) Recent Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Pediatric Gastrointestinal Drugs Introduction
11.7.4 GlaxoSmithKline Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024)
11.7.5 GlaxoSmithKline Recent Developments
11.8 Salix Pharmaceuticals
11.8.1 Salix Pharmaceuticals Company Details
11.8.2 Salix Pharmaceuticals Business Overview
11.8.3 Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Introduction
11.8.4 Salix Pharmaceuticals Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024)
11.8.5 Salix Pharmaceuticals Recent Developments
11.9 Perrigo
11.9.1 Perrigo Company Details
11.9.2 Perrigo Business Overview
11.9.3 Perrigo Pediatric Gastrointestinal Drugs Introduction
11.9.4 Perrigo Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024)
11.9.5 Perrigo Recent Developments
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott Pediatric Gastrointestinal Drugs Introduction
11.10.4 Abbott Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024)
11.10.5 Abbott Recent Developments
11.11 Honz Pharmaceutical
11.11.1 Honz Pharmaceutical Company Details
11.11.2 Honz Pharmaceutical Business Overview
11.11.3 Honz Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.11.4 Honz Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024)
11.11.5 Honz Pharmaceutical Recent Developments
11.12 Shandong DYNE Marine Biopharmaceutical
11.12.1 Shandong DYNE Marine Biopharmaceutical Company Details
11.12.2 Shandong DYNE Marine Biopharmaceutical Business Overview
11.12.3 Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.12.4 Shandong DYNE Marine Biopharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024)
11.12.5 Shandong DYNE Marine Biopharmaceutical Recent Developments
11.13 Sunflower Pharmaceutical
11.13.1 Sunflower Pharmaceutical Company Details
11.13.2 Sunflower Pharmaceutical Business Overview
11.13.3 Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.13.4 Sunflower Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024)
11.13.5 Sunflower Pharmaceutical Recent Developments
11.14 Jiangzhong Pharmaceutical
11.14.1 Jiangzhong Pharmaceutical Company Details
11.14.2 Jiangzhong Pharmaceutical Business Overview
11.14.3 Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.14.4 Jiangzhong Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024)
11.14.5 Jiangzhong Pharmaceutical Recent Developments
11.15 Yabao Pharmaceutical
11.15.1 Yabao Pharmaceutical Company Details
11.15.2 Yabao Pharmaceutical Business Overview
11.15.3 Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.15.4 Yabao Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024)
11.15.5 Yabao Pharmaceutical Recent Developments
11.16 Jumpcan Pharmaceutical
11.16.1 Jumpcan Pharmaceutical Company Details
11.16.2 Jumpcan Pharmaceutical Business Overview
11.16.3 Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.16.4 Jumpcan Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024)
11.16.5 Jumpcan Pharmaceutical Recent Developments
11.17 Hansen Pharmaceutical
11.17.1 Hansen Pharmaceutical Company Details
11.17.2 Hansen Pharmaceutical Business Overview
11.17.3 Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Introduction
11.17.4 Hansen Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024)
11.17.5 Hansen Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pediatric Gastrointestinal Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Tablets
Table 3. Key Players of Pills
Table 4. Key Players of Oral Liquid
Table 5. Global Pediatric Gastrointestinal Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 6. Global Pediatric Gastrointestinal Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 7. Global Pediatric Gastrointestinal Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Pediatric Gastrointestinal Drugs Market Share by Region (2018-2024)
Table 9. Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Pediatric Gastrointestinal Drugs Market Share by Region (2024-2034)
Table 11. Pediatric Gastrointestinal Drugs Market Trends
Table 12. Pediatric Gastrointestinal Drugs Market Drivers
Table 13. Pediatric Gastrointestinal Drugs Market Challenges
Table 14. Pediatric Gastrointestinal Drugs Market Restraints
Table 15. Global Pediatric Gastrointestinal Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Pediatric Gastrointestinal Drugs Revenue Share by Players (2018-2024)
Table 17. Global Top Pediatric Gastrointestinal Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Gastrointestinal Drugs as of 2022)
Table 18. Global Pediatric Gastrointestinal Drugs Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Pediatric Gastrointestinal Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Pediatric Gastrointestinal Drugs, Headquarters and Area Served
Table 21. Global Key Players of Pediatric Gastrointestinal Drugs, Product and Application
Table 22. Global Key Players of Pediatric Gastrointestinal Drugs, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pediatric Gastrointestinal Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Pediatric Gastrointestinal Drugs Revenue Market Share by Type (2018-2024)
Table 26. Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Pediatric Gastrointestinal Drugs Revenue Market Share by Type (2024-2034)
Table 28. Global Pediatric Gastrointestinal Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Pediatric Gastrointestinal Drugs Revenue Share by Application (2018-2024)
Table 30. Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Pediatric Gastrointestinal Drugs Revenue Share by Application (2024-2034)
Table 32. North America Pediatric Gastrointestinal Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Pediatric Gastrointestinal Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 34. North America Pediatric Gastrointestinal Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Pediatric Gastrointestinal Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 36. North America Pediatric Gastrointestinal Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 37. North America Pediatric Gastrointestinal Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Pediatric Gastrointestinal Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 39. Europe Pediatric Gastrointestinal Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Pediatric Gastrointestinal Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 41. Europe Pediatric Gastrointestinal Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Pediatric Gastrointestinal Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 43. Europe Pediatric Gastrointestinal Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 44. Europe Pediatric Gastrointestinal Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Pediatric Gastrointestinal Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 46. China Pediatric Gastrointestinal Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Pediatric Gastrointestinal Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 48. China Pediatric Gastrointestinal Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Pediatric Gastrointestinal Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 50. Asia Pediatric Gastrointestinal Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Pediatric Gastrointestinal Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 52. Asia Pediatric Gastrointestinal Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Pediatric Gastrointestinal Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 54. Asia Pediatric Gastrointestinal Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 55. Asia Pediatric Gastrointestinal Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Pediatric Gastrointestinal Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Size by Type (2024-2034) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Size by Application (2024-2034) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 62. Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 64. AstraZeneca Company Details
Table 65. AstraZeneca Business Overview
Table 66. AstraZeneca Pediatric Gastrointestinal Drugs Product
Table 67. AstraZeneca Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024) & (US$ Million)
Table 68. AstraZeneca Recent Developments
Table 69. Sanofi Company Details
Table 70. Sanofi Business Overview
Table 71. Sanofi Pediatric Gastrointestinal Drugs Product
Table 72. Sanofi Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024) & (US$ Million)
Table 73. Sanofi Recent Developments
Table 74. Aptalis Company Details
Table 75. Aptalis Business Overview
Table 76. Aptalis Pediatric Gastrointestinal Drugs Product
Table 77. Aptalis Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024) & (US$ Million)
Table 78. Aptalis Recent Developments
Table 79. Eisai Company Details
Table 80. Eisai Business Overview
Table 81. Eisai Pediatric Gastrointestinal Drugs Product
Table 82. Eisai Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024) & (US$ Million)
Table 83. Eisai Recent Developments
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Pediatric Gastrointestinal Drugs Product
Table 87. Pfizer Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024) & (US$ Million)
Table 88. Pfizer Recent Developments
Table 89. Zeria (Tillotts) Company Details
Table 90. Zeria (Tillotts) Business Overview
Table 91. Zeria (Tillotts) Pediatric Gastrointestinal Drugs Product
Table 92. Zeria (Tillotts) Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024) & (US$ Million)
Table 93. Zeria (Tillotts) Recent Developments
Table 94. GlaxoSmithKline Company Details
Table 95. GlaxoSmithKline Business Overview
Table 96. GlaxoSmithKline Pediatric Gastrointestinal Drugs Product
Table 97. GlaxoSmithKline Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024) & (US$ Million)
Table 98. GlaxoSmithKline Recent Developments
Table 99. Salix Pharmaceuticals Company Details
Table 100. Salix Pharmaceuticals Business Overview
Table 101. Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Product
Table 102. Salix Pharmaceuticals Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024) & (US$ Million)
Table 103. Salix Pharmaceuticals Recent Developments
Table 104. Perrigo Company Details
Table 105. Perrigo Business Overview
Table 106. Perrigo Pediatric Gastrointestinal Drugs Product
Table 107. Perrigo Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024) & (US$ Million)
Table 108. Perrigo Recent Developments
Table 109. Abbott Company Details
Table 110. Abbott Business Overview
Table 111. Abbott Pediatric Gastrointestinal Drugs Product
Table 112. Abbott Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024) & (US$ Million)
Table 113. Abbott Recent Developments
Table 114. Honz Pharmaceutical Company Details
Table 115. Honz Pharmaceutical Business Overview
Table 116. Honz Pharmaceutical Pediatric Gastrointestinal Drugs Product
Table 117. Honz Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024) & (US$ Million)
Table 118. Honz Pharmaceutical Recent Developments
Table 119. Shandong DYNE Marine Biopharmaceutical Company Details
Table 120. Shandong DYNE Marine Biopharmaceutical Business Overview
Table 121. Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Product
Table 122. Shandong DYNE Marine Biopharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024) & (US$ Million)
Table 123. Shandong DYNE Marine Biopharmaceutical Recent Developments
Table 124. Sunflower Pharmaceutical Company Details
Table 125. Sunflower Pharmaceutical Business Overview
Table 126. Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Product
Table 127. Sunflower Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024) & (US$ Million)
Table 128. Sunflower Pharmaceutical Recent Developments
Table 129. Jiangzhong Pharmaceutical Company Details
Table 130. Jiangzhong Pharmaceutical Business Overview
Table 131. Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Product
Table 132. Jiangzhong Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024) & (US$ Million)
Table 133. Jiangzhong Pharmaceutical Recent Developments
Table 134. Yabao Pharmaceutical Company Details
Table 135. Yabao Pharmaceutical Business Overview
Table 136. Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Product
Table 137. Yabao Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024) & (US$ Million)
Table 138. Yabao Pharmaceutical Recent Developments
Table 139. Jumpcan Pharmaceutical Company Details
Table 140. Jumpcan Pharmaceutical Business Overview
Table 141. Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Product
Table 142. Jumpcan Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024) & (US$ Million)
Table 143. Jumpcan Pharmaceutical Recent Developments
Table 144. Hansen Pharmaceutical Company Details
Table 145. Hansen Pharmaceutical Business Overview
Table 146. Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Product
Table 147. Hansen Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2018-2024) & (US$ Million)
Table 148. Hansen Pharmaceutical Recent Developments
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatric Gastrointestinal Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Pediatric Gastrointestinal Drugs Market Share by Type: 2022 VS 2034
Figure 3. Tablets Features
Figure 4. Pills Features
Figure 5. Oral Liquid Features
Figure 6. Global Pediatric Gastrointestinal Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Pediatric Gastrointestinal Drugs Market Share by Application: 2022 VS 2034
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Pediatric Gastrointestinal Drugs Report Years Considered
Figure 12. Global Pediatric Gastrointestinal Drugs Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Pediatric Gastrointestinal Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Pediatric Gastrointestinal Drugs Market Share by Region: 2022 VS 2034
Figure 15. Global Pediatric Gastrointestinal Drugs Market Share by Players in 2022
Figure 16. Global Top Pediatric Gastrointestinal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Gastrointestinal Drugs as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Pediatric Gastrointestinal Drugs Revenue in 2022
Figure 18. North America Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Pediatric Gastrointestinal Drugs Market Share by Type (2018-2034)
Figure 20. North America Pediatric Gastrointestinal Drugs Market Share by Application (2018-2034)
Figure 21. North America Pediatric Gastrointestinal Drugs Market Share by Country (2018-2034)
Figure 22. United States Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Canada Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Pediatric Gastrointestinal Drugs Market Size YoY (2018-2034) & (US$ Million)
Figure 25. Europe Pediatric Gastrointestinal Drugs Market Share by Type (2018-2034)
Figure 26. Europe Pediatric Gastrointestinal Drugs Market Share by Application (2018-2034)
Figure 27. Europe Pediatric Gastrointestinal Drugs Market Share by Country (2018-2034)
Figure 28. Germany Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. France Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. U.K. Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Italy Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Russia Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Nordic Countries Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. China Pediatric Gastrointestinal Drugs Market Size YoY (2018-2034) & (US$ Million)
Figure 35. China Pediatric Gastrointestinal Drugs Market Share by Type (2018-2034)
Figure 36. China Pediatric Gastrointestinal Drugs Market Share by Application (2018-2034)
Figure 37. Asia Pediatric Gastrointestinal Drugs Market Size YoY (2018-2034) & (US$ Million)
Figure 38. Asia Pediatric Gastrointestinal Drugs Market Share by Type (2018-2034)
Figure 39. Asia Pediatric Gastrointestinal Drugs Market Share by Application (2018-2034)
Figure 40. Asia Pediatric Gastrointestinal Drugs Market Share by Region (2018-2034)
Figure 41. Japan Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. South Korea Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. China Taiwan Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Southeast Asia Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. India Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Australia Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Size YoY (2018-2034) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Share by Type (2018-2034)
Figure 49. Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Share by Application (2018-2034)
Figure 50. Middle East, Africa, and Latin America Pediatric Gastrointestinal Drugs Market Share by Country (2018-2034)
Figure 51. Brazil Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 52. Mexico Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. Turkey Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. Saudi Arabia Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. Israel Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. GCC Countries Pediatric Gastrointestinal Drugs Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 57. AstraZeneca Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2024)
Figure 58. Sanofi Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2024)
Figure 59. Aptalis Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2024)
Figure 60. Eisai Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2024)
Figure 61. Pfizer Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2024)
Figure 62. Zeria (Tillotts) Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2024)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2024)
Figure 64. Salix Pharmaceuticals Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2024)
Figure 65. Perrigo Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2024)
Figure 66. Abbott Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2024)
Figure 67. Honz Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2024)
Figure 68. Shandong DYNE Marine Biopharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2024)
Figure 69. Sunflower Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2024)
Figure 70. Jiangzhong Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2024)
Figure 71. Yabao Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2024)
Figure 72. Jumpcan Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2024)
Figure 73. Hansen Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2018-2024)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed